SCHEMBL21200872

SCHEMBL21200872

Cc1cc(C(=O)Nc2cccc(C3([C@H](F)c4nncn4C)COC3)c2)nc(C2CC2)n1

nearest known ligand 0.68

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 20/20 0.68
▸ CBLC Q9ULV8 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21200466 1.00 CBLB (0.68) CBLBCBLC
SCHEMBL29866740 1.00 CBLB (0.68) CBLBCBLC
SCHEMBL21200018 1.00 CBLB (0.68) CBLBCBLC
SCHEMBL29867023 1.00 CBLB (0.68) CBLBCBLC
SCHEMBL26918903 0.87 CBLB (0.55) CBLBCBLC
SCHEMBL29998030 0.87 CBLB (0.55) CBLBCBLC
SCHEMBL29998936 0.87 CBLB (0.55) CBLBCBLC
SCHEMBL26918905 0.87 CBLB (0.55) CBLBCBLC
SCHEMBL29997890 0.85 CBLB (0.59) CBLBCBLC
SCHEMBL26922440 0.85 CBLB (0.59) CBLBCBLC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3743063-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF Nurix Therapeutics, Inc. (US) 2020-12-02 — — EP disclosed
WO-2019148005-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF NURIX THERAPEUTICS, INC. (US) 2019-08-01 — — WO disclosed
WO-2019148005-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF NURIX THERAPEUTICS, INC. (US) 2019-08-01 — — WO disclosed
Send feedback